Santiago, Pablito C.
HRN: 26-78-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/19/2025
03/25/2025
IV
500mg
Q12h
CAPHR
Waiting Final Action
Indication: Culture-directed Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes